UNII 2PP9364507

BETADEX SULFOBUTYL ETHER SODIUM

Unique Ingredient Identifier 2PP9364507 is listed as a ingredient substance
RN182410-00-0
NCITC80913
RXCUI1426608
MFC66H112O53S6.6Na
INCHI KEYVNDHXHMRJVTMTK-WZVRVNPQSA-H
SMILES[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@H](O[C@@H]3COCCCCS([O-])(=O)=O)O[C@H]4[C@H](O)[C@@H](O)[C@H](O[C@@H]4COCCCCS([O-])(=O)=O)O[C@H]5[C@H](O)[C@@H](O)[C@H](O[C@@H]5COCCCCS([O-])(=O)=O)O[C@H]6[C@H](O)[C@@H](O)[C@H](O[C@@H]6COCCCCS([O-])(=O)=O)O[C@H]7[C@H](O)[

Alternate Names

Dosage Forms

UNII 2PP9364507 BETADEX SULFOBUTYL ETHER SODIUM is commonly included in medications in the following forms.

RouteDosage FormPotency
INTRAMUSCULARPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH 44.15 %W/V
INTRAVENOUSINJECTION25 %
INTRAVENOUSPOWDER27 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION94.1 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED96.23 %
IV - SCSOLUTION, INJECTION400 MG/ML
IV(INFUSION)POWDER, FOR INJECTION SOLUTION, LYOPHILIZED16 %

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.